The latest announcement is out from Recce Pharmaceuticals Ltd. ( (AU:RCE) ).
Recce Pharmaceuticals Limited announced an equity raising initiative through a placement and entitlement offer of new fully paid ordinary shares. This move is aimed at bolstering the company’s financial resources to further its development and commercialization efforts. The offer is restricted to certain jurisdictions, emphasizing compliance with applicable securities laws, and is not available to investors in the United States.
More about Recce Pharmaceuticals Ltd.
Recce Pharmaceuticals Limited is a company operating in the biotechnology industry, focusing on the development and commercialization of a new class of synthetic anti-infectives.
YTD Price Performance: -28.12%
Average Trading Volume: 184,492
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$76.52M
Find detailed analytics on RCE stock on TipRanks’ Stock Analysis page.